Vaccines, Blood & Biologics
-
FEIBA NF (Anti-Inhibitor Coagulant Complex)
STN: BL 101447
Proper Name: Anti-Inhibitor Coagulant Complex
Tradename: FEIBA NF
Manufacturer: Baxter Healthcare Corp
Indication: For the control of spontaneous bleeding episodes or to cover surgical interventions in hemophilia A and hemophilia B patients with inhibitors
-
Supporting Documents
February 2, 2011 Approval Letter - FEIBA
Revise to supplement biologics license application.July 16, 2010 Approval Letter - FEIBA
Revised to add a boxed warning related to thrombotic and thromboembolic events following the infusion of this product.
-
-
Related Information
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.Dear Healthcare Provider: Risk of thrombotic and thromboembolic events following infusion of FEIBA VH or FEIBA NF (PDF - 39KB)
July 2010
-
-
-
